Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution
Clinical trial NCT03143725 · COMPLETED
Trial details
- NCT number
- NCT03143725
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-14
- Primary completion
- 2017-06-06
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.